About the special issue
Biological barriers throughout the body present significant challenges for successful drug delivery. Due to the limitations of current methods, novel strategies are constantly evolving to overcome these shortcomings. Therefore, Expert Opinion on Drug Delivery is excited to announce the 2023 Special Issue Series – “Overcoming biological barriers”.
This issue will focus on the biological barrier of the respiratory tract. The respiratory tract poses several challenges including mechanical, chemical, and immunological barriers but also lack of patient adherence or poor drug delivery techniques. Therefore, the field has been rapidly growing to overcome these obstacles.
With contributions from world-class key opinion leaders across academia and industry, the issue will cover all aspects of drug delivery via the respiratory tract. Topics of interest include, but are not limited to:
• Formulation of inhaled products (Solutions, suspensions, powders, nanoparticles, microparticles)
• Inhaled drug delivery devices (Nebulizers, metered-dose inhalers, dry powder inhalers, soft mist inhalers)
• Application of drug delivery approaches in different indications and patient groups
• Clinical safety and efficacy studies
The issue welcomes authors to submit relevant editorials, reviews, technology evaluations, interviews, and original research. The benefit of publishing as part of a special issue is that the articles included often receive more views and higher citation numbers.
If you are interested in contributing, or would like to learn more, then please reach out to the Commissioning Editor, Zoe Kenney, who will be happy to assist.